Location History:
- Jammu Tawi, IN (2015)
- Hyderabad, IN (2015 - 2016)
- Jammu, IN (2017 - 2018)
Company Filing History:
5 out of 2,096 
1 out of 5,015 
Years Active: 2015-2018
Title: Nitin Pal Kalia: Innovator in Anti-Tubercular Research
Introduction
Nitin Pal Kalia is a prominent inventor based in Jammu, India. He has made significant contributions to the field of medicinal chemistry, particularly in the development of potential anti-tubercular agents. With a total of 5 patents to his name, Kalia's work is paving the way for new treatments against tuberculosis.
Latest Patents
Kalia's latest patents include the synthesis of new benzothiazole derivatives that serve as potential anti-tubercular agents. These compounds are characterized by a general formula A, which includes 6-nitro-2,3-dihydroimidazo[2,1-b]oxazoles. His inventions also encompass a newer generation of triazoles, tetrazoles, isoxazoles, urea, and sulphonamide functionalities. These agents demonstrate acceptable pharmacokinetic properties and exhibit synergistic or additive effects when used in combination with existing anti-tubercular drugs, specifically targeting multidrug-resistant (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB).
Career Highlights
Throughout his career, Kalia has worked with esteemed organizations such as the Council of Scientific & Industrial Research and Colgate-Palmolive Company. His experience in these institutions has greatly influenced his research and development efforts in the pharmaceutical sector.
Collaborations
Kalia has collaborated with notable colleagues, including Inshad Ali Khan and Ahmed Kamal. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Nitin Pal Kalia's innovative work in the field of anti-tubercular research highlights his commitment to addressing critical health challenges. His contributions are essential in the ongoing fight against tuberculosis, showcasing the importance of innovation in medicine.